Skip to main content
. 2023 Jan 10;4(1):101961. doi: 10.1016/j.xpro.2022.101961

Table 1.

Detailed staining conditions and order of the Opal™-TSA mIHC 7-marker panel for human FFPE tissue sections

Primary antibody Antibody dilution (final concentration) Antibody incubation time Opal™ fluorophore (dilution)
Anti-human CD21 [1F8] 1:10 (199 μg/mL) Overnight (16–18 h) 520 (1:100)
Anti-human CD208/DC-LAMP 1:100 (10 μg/mL) 1 h 540 (1:100)
Anti-human CD4 [EPR6855] 1:1000 (0.143 μg/mL) 1 h 570 (1:100)
Anti-human PNAd [MECA-79] 1:100 (10 μg/mL) Overnight (16–18 h) 620 (1:100)
Anti-human CD8 alpha [C8/144B] 1:50 (10 μg/mL) 1 h 650 (1:100)
Anti-human CD19 [EPR5906] 1:300 (6.12 μg/mL) 1 h 690 (1:100)